• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估 2cm 作为功能性胰腺神经内分泌肿瘤治疗的截断值:一项基于人群的研究。

Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.

机构信息

Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jul 18;13:928341. doi: 10.3389/fendo.2022.928341. eCollection 2022.

DOI:10.3389/fendo.2022.928341
PMID:35923628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9339804/
Abstract

BACKGROUND

Expectant observation and aggressive surgery are both recommended for small nonfunctional pancreatic neuroendocrine tumors (NF-PanNETs). However, the optimal management of small NF-PanNETs remains disputable due to the heterogeneous clinical behavior.

METHODS

Patients who were diagnosed with pancreatic neuroendocrine neoplasms (PanNENs) between 2000 and 2018 were identified from the surveillance, epidemiology, and end results (SEER) database and reviewed retrospectively. Tumor aggressiveness was defined as poor differentiation, lymph node involvement, liver involvement, and advanced stage. The best cutoff of tumor size associated with tumor aggressiveness was determined through the receiver operating characteristic (ROC) curve analysis. Univariate and multivariate analyses were used to identify prognostic factors in patients with tumors of ≤2 cm.

RESULTS

A total of 5,172 patients with PanNENs were enrolled, including 1,760 (34.0%) tumors ≤2 cm and 3,412 (66.0%) tumors >2 cm. A 2.5-cm cutoff size was found to be associated with a satisfactory ability in predicting tumor aggressiveness. On multivariate analysis, age, gender, ethnicity, tumor grade, tumor number, and stage were independent prognostic factors for overall survival (OS) in patients with tumors less than or equal to 2 cm in size. A total of 1,621 patients were diagnosed with NF-PanNETs according to the WHO classification, of whom 1,350 underwent surgery, 271 performed active observation. The OS was significantly better in the surgery group compared to the observation group regardless of propensity score analysis. Additionally, a total of 407 patients were selected based on the multivariate Cox regression analysis, of whom 46 underwent observation, 361 underwent surgery, and the OS was comparable.

CONCLUSION

Expectant observation may be a reasonable alternative to aggressive surgical resection in highly selected small NF-PanNET patients. Also, the decision to observe versus surgery should not only be based on tumor size alone but also take into account other important clinicopathological factors.

摘要

背景

对于小的无功能性胰腺神经内分泌肿瘤(NF-PanNETs),建议进行期待观察和积极手术。然而,由于临床行为的异质性,小的 NF-PanNETs 的最佳治疗方法仍存在争议。

方法

从监测、流行病学和最终结果(SEER)数据库中确定了 2000 年至 2018 年间诊断为胰腺神经内分泌肿瘤(PanNENs)的患者,并进行回顾性复习。肿瘤侵袭性定义为分化差、淋巴结受累、肝转移和晚期。通过接受者操作特征(ROC)曲线分析确定与肿瘤侵袭性相关的最佳肿瘤大小截断值。使用单变量和多变量分析确定肿瘤大小≤2cm 的患者的预后因素。

结果

共纳入 5172 例 PanNENs 患者,其中 1760 例(34.0%)肿瘤≤2cm,3412 例(66.0%)肿瘤>2cm。发现 2.5cm 截断值与预测肿瘤侵袭性的能力相当。多变量分析显示,年龄、性别、种族、肿瘤分级、肿瘤数量和分期是肿瘤大小≤2cm 的患者总生存(OS)的独立预后因素。根据世界卫生组织(WHO)分类,共有 1621 例患者被诊断为 NF-PanNETs,其中 1350 例行手术,271 例行积极观察。与倾向评分分析无关,手术组的 OS 明显优于观察组。此外,根据多变量 Cox 回归分析,共选择了 407 例患者,其中 46 例观察,361 例手术,OS 相当。

结论

在高度选择的小 NF-PanNET 患者中,期待观察可能是积极手术切除的合理替代方案。此外,观察与手术的决定不应仅基于肿瘤大小,还应考虑其他重要的临床病理因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/81759d5f4c5d/fendo-13-928341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/a607fe45d521/fendo-13-928341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/e82a8fe3467e/fendo-13-928341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/821487d62588/fendo-13-928341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/893ad792b0a2/fendo-13-928341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/81759d5f4c5d/fendo-13-928341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/a607fe45d521/fendo-13-928341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/e82a8fe3467e/fendo-13-928341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/821487d62588/fendo-13-928341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/893ad792b0a2/fendo-13-928341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d230/9339804/81759d5f4c5d/fendo-13-928341-g005.jpg

相似文献

1
Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.重新评估 2cm 作为功能性胰腺神经内分泌肿瘤治疗的截断值:一项基于人群的研究。
Front Endocrinol (Lausanne). 2022 Jul 18;13:928341. doi: 10.3389/fendo.2022.928341. eCollection 2022.
2
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.手术与监测治疗分化良好、无功能性胰腺神经内分泌肿瘤:国家癌症数据库 11 年分析。
Oncologist. 2020 Feb;25(2):e276-e283. doi: 10.1634/theoncologist.2019-0466. Epub 2019 Oct 2.
3
Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.胰腺神经内分泌肿瘤的比较结果:基于 SEER 数据库的人群分析。
Eur J Surg Oncol. 2022 Oct;48(10):2181-2187. doi: 10.1016/j.ejso.2022.05.016. Epub 2022 May 21.
4
Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors.外科切除治疗小体积无功能性胰腺神经内分泌肿瘤患者的生存评估。
JAMA Netw Open. 2023 Mar 1;6(3):e234096. doi: 10.1001/jamanetworkopen.2023.4096.
5
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.散发性无功能性胰腺神经内分泌肿瘤:根据肿瘤大小判断淋巴结转移风险和侵袭性:一项多中心国际研究。
Surgery. 2022 Sep;172(3):975-981. doi: 10.1016/j.surg.2022.04.013. Epub 2022 May 24.
6
Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.预测无功能性胰腺神经内分泌肿瘤的侵袭性行为,重点关注肿瘤大小的意义和生存趋势:一项基于人群的1787例患者分析。
Am Surg. 2020 May;86(5):458-466. doi: 10.1177/0003134820919730.
7
Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model.使用 CT 影像组学-临床联合模型预测无功能性胰腺神经内分泌肿瘤的淋巴结转移。
Ann Surg Oncol. 2024 Nov;31(12):8136-8145. doi: 10.1245/s10434-024-16064-4. Epub 2024 Aug 23.
8
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.胰腺神经内分泌肿瘤的外科治疗原则。
Curr Treat Options Oncol. 2020 Apr 30;21(6):48. doi: 10.1007/s11864-020-00736-w.
9
Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.计算机断层扫描特征对无功能性胰腺神经内分泌肿瘤患者淋巴结受累情况的预测价值
Pancreas. 2017 Sep;46(8):1056-1063. doi: 10.1097/MPA.0000000000000888.
10
Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms.远端胰腺切除术治疗无功能性神经内分泌肿瘤后检查阳性淋巴结的预后作用。
Neuroendocrinology. 2021;111(8):728-738. doi: 10.1159/000509709. Epub 2020 Jun 25.

引用本文的文献

1
Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.胰腺神经内分泌肿瘤的手术治疗与非手术治疗:一项系统评价与Meta分析
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17819-3.
2
The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database.G1级胰腺神经内分泌肿瘤的风险及预后因素:美国监测、流行病学和最终结果(SEER)数据库的回顾性分析
Front Oncol. 2022 Oct 6;12:993524. doi: 10.3389/fonc.2022.993524. eCollection 2022.

本文引用的文献

1
Clinical Prognosticators of Metastatic Potential in Patients with Small Pancreatic Neuroendocrine Tumors.患者小胰腺神经内分泌肿瘤转移潜能的临床预后因素。
J Gastrointest Surg. 2021 Oct;25(10):2593-2599. doi: 10.1007/s11605-021-04946-x. Epub 2021 Mar 3.
2
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.胰腺神经内分泌肿瘤:治疗挑战与研究局限
World J Gastroenterol. 2020 Jul 28;26(28):4036-4054. doi: 10.3748/wjg.v26.i28.4036.
3
Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.
胰腺神经内分泌肿瘤:病理和影像学表现及分类的 2020 年更新。
Radiographics. 2020 Sep-Oct;40(5):1240-1262. doi: 10.1148/rg.2020200025. Epub 2020 Aug 14.
4
Surgical management of pancreatic neuroendocrine tumors: an introduction.胰腺神经内分泌肿瘤的外科治疗:引言。
Expert Rev Anticancer Ther. 2019 Dec;19(12):1089-1100. doi: 10.1080/14737140.2019.1703677. Epub 2019 Dec 17.
5
Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?美国早期胰腺神经内分泌肿瘤的手术切除:我们是否过度治疗或治疗不足?
Surgery. 2020 Jan;167(1):180-186. doi: 10.1016/j.surg.2019.04.061. Epub 2019 Sep 16.
6
A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.《以新的世界卫生组织分类为重点的胰腺神经内分泌肿瘤的临床病理和分子学更新》
Arch Pathol Lab Med. 2019 Nov;143(11):1317-1326. doi: 10.5858/arpa.2019-0338-RA. Epub 2019 Sep 11.
7
Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.对于无症状、无功能性的小型胰腺神经内分泌肿瘤,应选择切除还是观察?
J Gastrointest Surg. 2020 Jun;24(6):1366-1374. doi: 10.1007/s11605-019-04285-y. Epub 2019 Jun 13.
8
NCCN Guidelines Updates: Pancreatic Cancer.NCCN 指南更新:胰腺癌。
J Natl Compr Canc Netw. 2019 May 1;17(5.5):603-605. doi: 10.6004/jnccn.2019.5007.
9
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.分化良好的胰腺神经内分泌肿瘤的大小与 Ki67 增殖指数相关,与年龄无关。
Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22.
10
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?2017 年世界卫生组织分类和第 8 版美国癌症联合委员会胰腺神经内分泌肿瘤分期系统有哪些新内容?
Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27.